Well, the fact that the statistically significant results show that another trial is a good idea, having the money to fund such a trial becomes the issue. No, I don't believe that CYDY will see money from Amarex in time for that. It's partnership or bust, I think. I hope I'm wrong and they're deep in partnership talks, but as I have said, the release of the data without word of partnership concurrently makes me think there is nothing imminent.

That being said, as long as the share price keeps going up, it gives me hope that something is in the works other than "We are actively looking for a partner."